CNS and oncology biotech with AI-driven drug discovery and clinical data platforms
SK Life Science is a U.S. pharma subsidiary focused on CNS disorders and oncology, operating a modern data and AI stack (Python, Spark, Snowflake, dbt, LangChain, PyTorch, Hugging Face) that reflects a shift toward computational drug discovery and real-time decision intelligence. Active hiring across healthcare, engineering, and marketing—with director-level openings—signals expansion in clinical operations and AI tooling to address internal bottlenecks in data integration, workflow automation, and drug discovery velocity.
Notable leadership hires: Marketing Director, Medical Director
SK Life Science, Inc. is a U.S. subsidiary of SK Biopharmaceuticals, part of SK Group, headquartered in Paramus, New Jersey. The company develops treatments for central nervous system disorders and oncology, targeting physician and patient audiences through key opinion leader engagement, medical education, and congress-facing programs. With 201–500 employees, the organization operates across R&D, clinical operations, regulatory, and commercial functions. Current focus areas include master data governance, clinical decision-support platforms, and automated workflows to reduce manual operational drag and accelerate prescription uptake.
Python, Apache Spark, Apache Airflow, Docker, Kubernetes, AWS, Azure, Snowflake, dbt, SAP, Veeva, IQVIA, LangChain, PyTorch, Hugging Face, and Tableau. The mix shows investment in data engineering, ML, and clinical data management infrastructure.
United States and Canada. Hiring activity is concentrated in North America across clinical, commercial, and engineering functions.
SK Life Science, Inc.'s technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.